These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6408760)

  • 1. Motor disabilities and effects of thyrotropin-releasing hormone on ataxia of spinocerebellar degeneration.
    Kimura I; Ohtomo H; Kogure K
    Tohoku J Exp Med; 1983 Apr; 139(4):331-7. PubMed ID: 6408760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute and chronic effects of thyrotropin-releasing hormone (TRH) on stabilogram in spinocerebellar degenerations.
    Yoshida M; Nakanishi T; Komatsu Y
    Tohoku J Exp Med; 1986 Mar; 148(3):327-31. PubMed ID: 3085285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled trial of thyrotropin releasing hormone tartrate in ataxia of spinocerebellar degenerations.
    Sobue I; Takayanagi T; Nakanishi T; Tsubaki T; Uono M; Kinoshita M; Igata A; Miyazaki M; Yoshida M; Ando K
    J Neurol Sci; 1983 Oct; 61(2):235-48. PubMed ID: 6417282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of thyrotropin releasing hormone (TRH) on motor execution and motor adaptation process in patients with spinocerebellar degeneration.
    Shimizu T; Tsutsumi R; Shimizu K; Tominaga N; Nagai M; Ugawa Y; Nishiyama K; Hanajima R
    J Neurol Sci; 2020 Aug; 415():116927. PubMed ID: 32474221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The long loop reflex in spinocerebellar degeneration and motor neuron disease--its changes with TRH therapy.
    Touge T; Takeuchi H; Yamada A; Miki H; Nishioka M
    Electromyogr Clin Neurophysiol; 1990; 30(3):131-40. PubMed ID: 2112456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of the thyrotropin releasing hormone (TRH) on the motor speech disorder in spinocerebellar degeneration].
    Nozaki Y; Hashimoto M; Ohnishi A; Murai Y; Ogata H; Makishima K
    J UOEH; 1992 Jun; 14(2):173-83. PubMed ID: 1621012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spinocerebellar degenerations--clinical aspects and new treatment of ataxia.
    Sobue I
    Jpn J Med; 1985 Feb; 24(1):62-7. PubMed ID: 3923240
    [No Abstract]   [Full Text] [Related]  

  • 8. [Spinocerebellar degenerations].
    Sobue I
    Nihon Naika Gakkai Zasshi; 1984 Oct; 73(10):1415-31. PubMed ID: 6440937
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy of thyrotropin-releasing hormone in the treatment of cerebellar ataxia.
    Takeuchi Y; Fujiwara K; Ishimura K; Shimada Y; Ochi M; Yoshioka H; Sawada T
    Pediatr Neurol; 1989; 5(2):107-10. PubMed ID: 2469426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy of TRH-T for spinocerebellar degeneration--the relation between clinical features and effect of TRH therapy].
    Waragai M; Ogawara K; Takaya Y; Hayashi M
    Rinsho Shinkeigaku; 1997 Jul; 37(7):587-94. PubMed ID: 9396355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the effect of thyrotropin releasing hormone (TRH) on regional cerebral blood flow in spinocerebellar degeneration using 3DSRT.
    Kimura N; Kumamoto T; Masuda T; Nomura Y; Hanaoka T; Hazama Y; Okazaki T; Arakawa R
    J Neurol Sci; 2009 Jun; 281(1-2):93-8. PubMed ID: 19286195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chronic experimentation with TRH administered intramuscularly in spinocerebellar degeneration. Double-blind cross-over study in 30 subjects].
    Filla A; De Michele G; Di Martino L; Mengano A; Iorio L; Maggio MA; Campanella G
    Riv Neurol; 1989; 59(2):83-8. PubMed ID: 2505370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of Cockayne syndrome with cerebellar ataxia improved after TRH therapy (author's transl)].
    Naito H
    Horumon To Rinsho; 1982 Mar; 30(3):261-6. PubMed ID: 6807582
    [No Abstract]   [Full Text] [Related]  

  • 14. TRH treatment in cerebellar ataxia following a lightning stroke.
    Morocutti C; Spadaro M; Amabile G
    Ital J Neurol Sci; 1989 Oct; 10(5):531. PubMed ID: 2509400
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of tartrate thyrotropin-releasing hormone treatment on serum thyrotropin, free triiodothyronine, free thyroxine and prolactin levels in patients with spinocerebellar degeneration.
    Merola B; Colao A; Di Renzo G; Filla A; Campanella G; Lombardi G
    Horm Res; 1992; 38(3-4):160-3. PubMed ID: 1306848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical studies of spinocerebellar degeneration].
    Sohue I
    Nihon Naika Gakkai Zasshi; 1984 Feb; 73(2):175-8. PubMed ID: 6427370
    [No Abstract]   [Full Text] [Related]  

  • 17. Alterations in local cerebral glucose metabolism and endogenous thyrotropin-releasing hormone levels in rolling mouse Nagoya and effect of thyrotropin-releasing hormone tartrate.
    Nakayama T; Nagai Y
    Jpn J Pharmacol; 1996 Nov; 72(3):241-6. PubMed ID: 8957685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pharmacological effect of thyrotropin-releasing hormone on ataxic mutant mice.
    Mano Y; Matsui K; Toyoshima E; Ando K
    Acta Neurol Scand; 1986 Apr; 73(4):352-8. PubMed ID: 3088901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral thyrotropin-releasing hormone treatment in inherited ataxias.
    Bonuccelli U; Nuti A; Cei G; Rossi G; Grasso L; Martino E; Muratorio A
    Clin Neuropharmacol; 1988 Dec; 11(6):520-8. PubMed ID: 3148366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the effects of thyrotropin releasing hormone (TRH) therapy on regional cerebral blood flow in the cerebellar variant of multiple system atrophy using 3DSRT.
    Kimura N; Kumamoto T; Masuda T; Nomura Y; Hanaoka T; Hazama Y; Okazaki T
    J Neuroimaging; 2011 Apr; 21(2):132-7. PubMed ID: 19674246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.